VIRO.CO
Price:
$15.45
Market Cap:
$119.51M
ViroGates A/S develops and markets prognostic products for the healthcare sector. It offers suPARnostic, a blood test that measures the soluble urokinase plasminogen activator receptor (suPAR) protein in the bloodstream used for emergency departments in hospitals to improve clinical decisions on hospitalization or discharge of acute medical patients and reduce healthcare cost. The company also provides suPARnostic TurbiLatex, a latex particle-enhanced turbidimetric immunoassay that quantitatively determines the suPAR level in human K2-EDTA- or lithium heparin plasma samples; suPARnostic Quick Triage kit, which is used in the point of care situation for early warning and patient triaging; and...[Read more]
Industry
Medical - Devices
IPO Date
2018-06-26
Stock Exchange
CPH
Ticker
VIRO.CO
According to ViroGates A/S’s latest financial reports and current stock price. The company's current Enterprise Value is 112.68M. This represents a change of 117.16% compared to the average of 51.89M of the last 4 quarters.
The mean historical Enterprise Value of ViroGates A/S over the last ten years is 200.02M. The current 112.68M Enterprise Value has changed 5.53% with respect to the historical average. Over the past ten years (40 quarters), VIRO.CO's Enterprise Value was at its highest in in the September 2021 quarter at 518.09M. The Enterprise Value was at its lowest in in the June 2017 quarter at 0.
Average
200.02M
Median
173.44M
Minimum
11.35M
Maximum
573.96M
Discovering the peaks and valleys of ViroGates A/S Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 461.20%
Maximum Annual Enterprise Value = 573.96M
Minimum Annual Increase = -92.88%
Minimum Annual Enterprise Value = 11.35M
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 63.72M | 461.20% |
| 2023 | 11.35M | -92.88% |
| 2022 | 159.40M | -72.23% |
| 2021 | 573.96M | 96.41% |
| 2020 | 292.23M | 212.70% |
| 2019 | 93.45M | -37.79% |
| 2018 | 150.23M | -19.87% |
| 2017 | 187.49M | -21.06% |
| 2016 | 237.52M | 2.89% |
The current Enterprise Value of ViroGates A/S (VIRO.CO) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
78.16M
5-year avg
220.13M
10-year avg
200.02M
ViroGates A/S’s Enterprise Value is less than Scandinavian Medical Solutions A/S (154.07M), less than Pharma Equity Group A/S (144.19M), greater than Stenocare A/S (60.15M), greater than Monsenso A/S (11.37M), greater than Brain+ A/S (6.76M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 154.07M | $105.49M | |
| 144.19M | $126.44M | |
| 60.15M | $62.19M | |
| 11.37M | $12.75M | |
| 6.76M | $11.10M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ViroGates A/S using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like ViroGates A/S or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is ViroGates A/S's Enterprise Value?
What is the highest Enterprise Value for ViroGates A/S (VIRO.CO)?
What is the 3-year average Enterprise Value for ViroGates A/S (VIRO.CO)?
What is the 5-year average Enterprise Value for ViroGates A/S (VIRO.CO)?
How does the current Enterprise Value for ViroGates A/S (VIRO.CO) compare to its historical average?